🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates KRT-232, a novel oral small molecule inhibitor of MDM2...
Status
Unknown
Location
University of Alabama Birmingham
Start Date
2021-05-07
Trial ID
NCT04835584
To assess the feasibility of oral dasatinib pulses (3 consecutive days per ...
Status
Active Not Recruiting
Location
Stanford University
Start Date
2023-10-02
Trial ID
NCT05993949
Treatments Being Tested
The purpose of this study is to: * Find out if the study drugs Afatinib an...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2013-12-31
Trial ID
NCT01999985
Treatments Being Tested
The objective of this protocol is to improve survival for adults with acute...
Status
Terminated
Location
UCSD, Division of Blood and Marrow Transplantation, Moores Cancer Center
Start Date
2014-01
Trial ID
NCT02043587
Treatments Being Tested
The purpose of this study is to find a dose of Nivolumab that can be safely...
Status
Completed
Location
Winship Cancer Institute
Start Date
2014-02-07
Trial ID
NCT02011945
The primary objective of the Phase Ib study is to determine the dose-limiti...
Status
Withdrawn
Location
The University of Texas M.D. Anderson Cancer Center
Start Date
2017-09-01
Trial ID
NCT02923986
Treatments Being Tested
The goal of this clinical trial is to learn if KQB198 works to treat advanc...
Status
Active Not Recruiting
Location
University of California, San Francisco (UCSF)
Start Date
2024-12-09
Trial ID
NCT06645886
This study evaluates the use of ETC-1907206 in combination with dasatinib i...
Status
Withdrawn
Location
Winship Cancer Institute, Emory University
Start Date
2018-04-25
Trial ID
NCT03414450
Treatments Being Tested